Reference health

American Equity Rights Security Offerings - A Distinctive Class of Financial Transactions (Notes on 'European' Rights Including HSBC/Goldman Sachs)

https://doi.org/10.2139/ssrn.1430711
CiteStamped reference-health badge
3/3 checkable references clean · checked 2026-07-24

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

22 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 3 checked references that resolve
resolves10.1007/978-1-4302-0116-8_10
Testing COM and Web Services
resolves10.1093/ww/9780199540884.013.22049
Jillings, Godfrey Frank, (born 24 May 1940), Deputy Chairman, Gladedale Holdings plc, 2000–09
resolves10.2139/ssrn.1156116
Accelerated Stock Repurchase Programs: Underreported and Overpriced? KLA-Tencor Addendum
The 22 references without a DOI — listed, not checked
no DOI — not checkedref1
no DOI — not checkedref4
no DOI — not checkedref5
no DOI — not checkedref8
no DOI — not checkedref9
no DOI — not checkedref12
no DOI — not checkedref13
no DOI — not checkedref16
no DOI — not checkedref17
no DOI — not checkedReinforces the view that ASRs provide inferior risk/reward relative to simple alternatives (inefficient execution), carry liability (ASRs are denied a 10b-18 safe harbor against charges of manipulation), show disturbing, pre-deal, stock activity (prices rise 10% shortly preceding an ASR), and may offer idiosyncratic, incomplete, or misleading disclosures
no DOI — not checkedJagolinzer: 10b5-1 "Use/Misuse" -The Upcoming Scrutiny and Debate -Should 10b5-1 Order Instructions Be Disclosed? Conclusion: Summarizes the competing claims of Sen and Jagolinzer on the implications of stock price performance subsequent to 10b5-1 sales
no DOI — not checkedref22
no DOI — not checkedref23
no DOI — not checkedref24
no DOI — not checkedref26
no DOI — not checkedref27
no DOI — not checkedS&P 500 buybacks peaked at $589 billion. If all buybacks were executed at the rate paid by Microtune, commissions on buybacks would have been $2.9 billion. Is the Microtune transaction representative? Are buyback commission and expense fees high? If high, does that reflect the cost of regulatory compliance, or do companies just pay too much? If answers to these questions must hinge on the inadvertent release of commission data by a single company for a single month
no DOI — not checkedref29
no DOI — not checkedref30
no DOI — not checkedref31
no DOI — not checkedref34
no DOI — not checkedref35
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.1430711"><img src="https://citestamp.com/citestamped/10.2139/ssrn.1430711/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.1430711/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.1430711)